Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors
MSC-1 (AZD0171) 是一种人源化抗白血病抑制因子单克隆抗体,用于治疗晚期实体瘤,这是一项 I 期首次人体试验。
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100530
Borazanci, E; Schram, A M; Garralda, E; Brana, I; Vieito Villar, M; Spreafico, A; Oliva, M; Lakhani, N J; Hoffman, K; Hallett, R M; Maetzel, D; Hua, F; Hilbert, J; Giblin, P; Anido, J; Kelly, A; Vickers, P J; Wasserman, R; Seoane, J; Siu, L L; Hyman, D M; Hoff, D V; Tabernero, J